Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL - Abramson, J S; Gordon, L I; Palomba, M L (J Clin Oncol, 2018)
. Im Internet: https://doi.org/10.1200/JCO.2018.36.15_suppl.7505